E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10919674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products

  2000cited by this paper
• Transactivation of the Human cdc2 Promoter by Adenovirus E1A

  1999cited by this paper
• p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.

  1999cited by this paper
• Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo

  1998cited by this paper
• Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

  1998cited by this paper
• E1A signaling to p53 involves the p19(ARF) tumor suppressor.

  1998cited by this paper
• Deregulation of cdc2 gene expression correlates with overexpression of a 110 kDa CCAAT box binding factor in transformed cells.

  1998cited by this paper
• Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.

  1998cited by this paper
• Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells.

  1998cited by this paper
• p14ARF links the tumour suppressors RB and p53

  1998cited by this paper
• The Early Region 4 orf4 Protein of Human Adenovirus Type 5 Induces p53-Independent Cell Death by Apoptosis

  1998cited by this paper
• BCR – ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner

  1998cited by this paper
• E4orf4, a Novel Adenovirus Death Factor That Induces p53-independent Apoptosis by a Pathway That Is Not Inhibited by zVAD-fmk

  1998cited by this paper
• BCR-ABL delays apoptosis upstream of procaspase-3 activation.

  1998cited by this paper
• a Novel Adenovirus Death Factor That Induces p 53-independent Apoptosis by a Pathway That Is Not Inhibited by zVAD-fmk

  1998cited by this paper
• A signaling to p 53 involves the p 19 ARF tumor suppressor

  1998cited by this paper
• Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.

  1998cited by this paper
• Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

  1998cited by this paper
• Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor

  1998cited by this paper
• Herbimycin A accelerates the induction of apoptosis following etoposide treatment or γ-irradiation of bcr/abl-positive leukaemia cells

  1998cited by this paper
• The role of the Caspase family of cysteine proteases in apoptosis.

  1997cited by this paper
• Role of Bcr-Abl kinase in resistance to apoptosis.

  1997cited by this paper
• Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.

  1997cited by this paper
• Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry.

  1997cited by this paper
• Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis.

  1997cited by this paper
• The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer*

  1997cited by this paper
• DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

  1997cited by this paper
• Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.

  1997cited by this paper
• Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis

  1997cited by this paper
• E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis

  1997cited by this paper
• E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

  1997cited by this paper
• Functional aspects of apoptosis in hematopoiesis and consequences of failure.

  1997cited by this paper
• ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block.

  1996cited by this paper
• Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis

  1996cited by this paper
• Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.

  1996cited by this paper
• Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene.

  1996cited by this paper
• Inhibition of intratracheal lung cancer development by systemic delivery of E1A.

  1996cited by this paper
• Specific loss of apoptotic but not cell‐cycle arrest function in a human tumor derived p53 mutant.

  1996cited by this paper
• Apoptosis-the story so far...

  1996cited by this paper
• Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase.

  1996cited by this paper
• Degradation of Topoisomerase IIα during Adenovirus E1A-induced Apoptosis Is Mediated by the Activation of the Ubiquitin Proteolysis System*

  1996cited by this paper
• Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death

  1996cited by this paper
• Regulation of the Fas Apoptotic Cell Death Pathway by Abl (*)

  1995cited by this paper
• The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.

  1995cited by this paper
• Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms.

  1995cited by this paper
• Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.

  1995cited by this paper
• Rescue from granzyme B-induced apoptosis by Wee1 kinase

  1995cited by this paper
• BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.

  1995cited by this paper
• Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

  1995cited by this paper
• BCR-ABL: an anti-apoptosis gene in chronic myelogenous leukemia.

  1995cited by this paper
• Premature p34cdc2 activation required for apoptosis.

  1994cited by this paper
• Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.

  1994cited by this paper
• Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block.

  1994cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.

  1994cited by this paper
• Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.

  1994cited by this paper
• Control of p53-dependent apoptosis by E1B, Bcl-2, and Ha-ras proteins.

  1994cited by this paper
• Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line.

  1993cited by this paper
• Regulation of Apoptosis by the Transforming Genes of the DNA Tumor Virus Adenovirus

  1993cited by this paper
• Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.

  1993cited by this paper
• Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

  1993cited by this paper
• BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.

  1993cited by this paper
• Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.

  1993cited by this paper
• Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.

  1993cited by this paper
• The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins

  1992cited by this paper
• The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

  1992cited by this paper
• Electroporation in 'intracellular' buffer increases cell survival.

  1992cited by this paper
• Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes.

  1991cited by this paper
• Leukemia and the disruption of normal hematopoiesis.

  1991cited by this paper
• E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products

  1991cited by this paper
• Antioncogenic effect of adenovirus E1A in human tumor cells.

  1991cited by this paper
• Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells.

  1990cited by this paper
• Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase

  1990cited by this paper
• Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis.

  1990cited by this paper
• Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia

  1989cited by this paper
• p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression

  1988cited by this paper
• Two regions of the adenovirus early region 1A proteins are required for transformation

  1988cited by this paper
• Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?

  1988cited by this paper
• Chronic myelogenous leukemia: recent advances.

  1985cited by this paper
• Chronic myelogenous leukemia--new concepts (first of two parts).

  1981cited by this paper
• p 53 in chronic myelogenous leukemia in acute phase ( blast crisis / suppressor genes / allele loss )

  year unknowncited by this paper

• MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells

  2015cites this paper
• E1a promotes c-Myc-dependent replicative stress

  2014cites this paper
• DNA Repair Mechanisms in Other Cancer Stem Cell Models

  2013cites this paper
• MJ-29 Inhibits Tubulin Polymerization, Induces Mitotic Arrest, and Triggers Apoptosis via Cyclin-Dependent Kinase 1-Mediated Bcl-2 Phosphorylation in Human Leukemia U937 Cells

  2010cites this paper
• Addressing the challenge: current and future directions in ovarian cancer therapy.

  2009cites this paper
• Biodistribution and kinetics of the novel selective oncolytic adenovirus M1 after systemic administration

  2008cites this paper
• Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.

  2007cites this paper
• ATR-Chk1 Axis Protects BCR/ABL Leukemia Cells from the Lethal Effect of DNA Double-Strand Breaks

  2006cites this paper
• Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin

  2005cites this paper
• Adenovirus E1A gene-induced tumor cell rejection through cellular sensitization to immune and nonimmune apoptotic injuries.

  2005cites this paper
• A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-Lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing HER-2/neu Oncogene

  2004cites this paper
• Genetic Alteration in Chronic Myeloid Leukemia : Translocation

  2004cites this paper
• Abi Enhances Abl-Mediated Cdc2 Phosphorylation and Inactivation

  2004cites this paper
• Medication selection by genotype: How genetics is changing drug prescribing and efficacy.

  2004cites this paper
• The Adenovirus E3 Promoter Is Sensitive to Activation Signals in Human T Cells

  2003cites this paper
• E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.

  2003cites this paper
• RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines

  2003cites this paper
• DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells.

  2003cites this paper
• Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.

  2002cites this paper
• Toward a New Generation of Conditionally Replicating Adenoviruses: Pairing Tumor Selectivity with Maximal Oncolysis

  2002cites this paper
• The Adenovirus E 3 Promoter Is Sensitive to Activation Signals in Human T Cells

  2002cites this paper
• In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.

  2002cites this paper
• Cancer therapy utilizing an adenoviral vector expressing only E1A

  2002cites this paper
• Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G2/M Phase, and Protection from Apoptosis

  2002cites this paper
• Role of the E1A Rb-binding domain in repression of the NF-κB-dependent defense against tumor necrosis factor-α

  2002cites this paper
• Oncogenic tyrosine kinases and the dna-damage response

  2002cites this paper
• The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy

  2001cites this paper
• Dissecting the apoptotic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer therapies

  2001cites this paper